• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immun Inflamm Dis . Impact of Inactivated Influenza Vaccination on Health-Related Quality of Life Among Japanese Healthcare Workers

tetano

Editor, Senior Moderator
Immun Inflamm Dis


. 2025 Sep;13(9):e70266.
doi: 10.1002/iid3.70266. Impact of Inactivated Influenza Vaccination on Health-Related Quality of Life Among Japanese Healthcare Workers

Taito Kitano[SUP] 1 2 [/SUP], Sayaka Yoshida[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Influenza vaccinations are recommended for healthcare workers (HCWs). Quantification of the personal risks of vaccination compared to vaccine benefits can help guide more accurate benefit-risk assessment and cost-effectiveness analysis of inactivated influenza vaccination among HCWs. The study objective was to evaluate the quality-adjusted life day (QALD) loss due to adverse events following immunization (AEFI) among HCWs.
Methods: This study used a questionnaire survey with the EuroQol-5 dimension-5 level (EQ-5D) for HCWs to evaluate the impact of reactogenicity on QALD loss following inactivated seasonal influenza vaccination. Participants were asked to answer a questionnaire survey regarding their health status once daily from the day before vaccination until 7 days after vaccination (a total of 9 times). QALD loss was calculated as the cumulative difference between the mean EQ-5D scores following vaccination (Days 0-7) and the mean EQ-5D score before vaccination (Day -1).
Results: During the study period, 213 participants completed the surveys for 5 days or more, and 122 participants completed the surveys for all days. The mean QALD losses among the participants who completed the surveys for five or more days and those who completed the surveys on all days were 0.040 and 0.054, respectively. The mean QALD losses among those by grade (the maximal grade of any AEFIs) were 0.021 (grade 0), -0.018 (grade 1), 0.089 (grade 2), and 0.299 (grade 3), respectively.
Conclusion: We measured the magnitude of QALD loss in HCWs following inactivated influenza vaccination. These results support a more accurate health technology assessment of seasonal influenza vaccination in this population.

Keywords: health personnel; influenza; quality of life; quality‐adjusted life years; safety; vaccination.

 
Back
Top Bottom